Ozempic maker warns doctors against writing compounded scripts due to ‘potential safety risks’
Semaglutide maker Novo Nordisk has hit back at GPs prescribing compounded versions of its blockbuster drug. Semaglutide (Ozempic) was already under scrutiny for mass off-label…